← Back to Search

Behavioral Intervention

Genetic Counseling Support for Breast Cancer

N/A

Recruiting

Led By Kent Hoskins, MD

Research Sponsored by University of Illinois at Chicago

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 25 or older

Female

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 56 weeks

Awards & highlights

Study Summary

This trial will test the effectiveness of a culturally targeted video on promoting genetic counseling attendance among African American women determined to be at high risk for breast cancer.

Who is the study for?

This trial is for African American women aged 25 or older who have been identified as high risk for breast cancer through a genetic risk assessment and have not previously received genetic counseling. Participants must speak and understand English.Check my eligibility

What is being tested?

The study is testing the effectiveness of a culturally targeted video versus an informational brochure in encouraging attendance at genetic counseling sessions among high-risk African American women.See study design

What are the potential side effects?

Since this trial involves educational materials rather than medical treatments, there are no direct physical side effects. However, learning about one's potential health risks could potentially cause emotional distress.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 25 years old or older.

Select...

I am female.

Select...

I am at high risk for breast cancer according to a genetic risk assessment.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 56 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~56 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 56 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Genetic Counseling Attendance

Secondary outcome measures

Decision Aid Usability

Diffusion of Knowledge

Distress Associated with Genetic Counseling and Breast Cancer Risk

+3 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Decision aid videoExperimental Treatment1 Intervention

Participants receiving the intervention will complete a pretest, watch the decision aid video, and complete posttest via tablet computer facilitated by Patient Navigators.

Group II: Genetic counseling informational brochureActive Control1 Intervention

Participants receiving the control will complete pretest, review a genetic counseling brochure with the Patient Navigators, and complete posttest via tablet computer facilitated by a Patient Navigator.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor

609 Previous Clinical Trials

1,559,203 Total Patients Enrolled

11 Trials studying Breast Cancer

1,342,356 Patients Enrolled for Breast Cancer

National Cancer Institute (NCI)NIH

13,665 Previous Clinical Trials

40,925,748 Total Patients Enrolled

940 Trials studying Breast Cancer

1,543,360 Patients Enrolled for Breast Cancer

Kent Hoskins, MDPrincipal InvestigatorUniversity of Illinois at Chicago

Media Library

Decision aid video (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04378751 — N/A

Breast Cancer Research Study Groups: Genetic counseling informational brochure, Decision aid video

Breast Cancer Clinical Trial 2023: Decision aid video Highlights & Side Effects. Trial Name: NCT04378751 — N/A

Decision aid video (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04378751 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are recruitments for this clinical trial still open?

"Clinicaltrials.gov reports that this particular trial, which was initially posted on November 1st 2022 and has since seen its last update on October 7th 2022, is no longer enrolling participants. Nevertheless, there are currently 2289 other medical studies actively recruiting patients at the present moment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Promoting Genetic Counseling Among African American Women With a Family History of Breast Cancer

Kent F. Hoskins, MD 2023. "Promoting Genetic Counseling Among African American Women With a Family History of Breast Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04378751.

All > Breast Cancer Chicago